Bio-Techne Corp

Common Name
Bio-Techne
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
3,100
Ticker
TECH
Exchange
NASDAQ/NGS
Description
Bio-Techne Corporation is a leading developer and manufacturer of high-quality biological products and solutions for the research and clinical diagnostic markets. The company specializes in providing ...

Bio-Techne's GHG Emissions Data Preview

In 2023, Bio-Techne completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Bio-Techne has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind Bio-Techne’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Bio-Techne’s data sources below and access millions more through our Disclosure Search.

a. Bio-Techne's Sustainability Report 2024
a. Bio-Techne's Sustainability Report 2024

Insights into Bio-Techne's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Bio-Techne amounted to 17,566 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Bio-Techne decreased by 0.15%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

Bio-Techne's Scope 1 Emissions Over Time

20212022202309501.9 k2.85 k3.8 ktCO2e+41%-21%
  • Total Scope 1
  • Year-over-Year Change

What are Bio-Techne's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Bio-Techne were 3,001 metric tons of CO₂ equivalent (tCO₂e). a

Has Bio-Techne reduced its Scope 1 emissions over time?

Since 2021, Bio-Techne's Scope 1 emissions have increased by 11.81%, reflecting a rising long-term trend in Scope 1 emissions over time. a

Compared to the previous year (2022), Bio-Techne's Scope 1 emissions decreased by 20.63%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a

What are Bio-Techne's Scope 2 emissions?

In 2023, Bio-Techne reported Scope 2 greenhouse gas (GHG) emissions of 14,565 tCO₂e using the location-based method. a

Has Bio-Techne reduced its Scope 2 emissions over time?

Since 2021, Bio-Techne's Scope 2 greenhouse gas (GHG) emissions ( Location-Based) have increased by 14.74%, reflecting a rising long-term trend in Scope 2 emissions over time. a

Compared to the previous year (2022), Bio-Techne's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Bio-Techne 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does Bio-Techne use for Scope 2 reporting?

In 2023, Bio-Techne reported its Scope 2 emissions using the location-based method. a

Bio-Techne's Scope 2 Emissions Over Time

20212022202304 k8 k12 k16 ktCO2e
  • Total Scope 2 Location-Based

Insights into Bio-Techne’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Bio-Techne reported Scope 1 greenhouse gas (GHG) emissions of 3,001 tCO₂e and total revenues of USD 1,137 millions. This translates into an emissions intensity of 2.64 tCO₂e per millions USD. a

Bio-Techne's Scope 1 Emissions Intensity Compared to Peers

1005005,00020,000200,000Scope 1 Emissions (tCO2e)101005005,00050,000Revenues (Millions of USD)RIncyteYear: 2024Scope 1: 9,576 tCO2eRevenue: $M 4,241Scope 1 Intensity: 2.26 tCO2e/$MInsmedYear: 2024Scope 1: 1,666 tCO2eRevenue: $M 364Scope 1 Intensity: 4.58 tCO2e/$MInsuletYear: 2024Scope 1: 1,383 tCO2eRevenue: $M 2,072Scope 1 Intensity: 0.67 tCO2e/$MLegend BiotechYear: 2024Scope 1: 769 tCO2eRevenue: $M 627Scope 1 Intensity: 1.23 tCO2e/$MExact SciencesYear: 2024Scope 1: 12,121 tCO2eRevenue: $M 2,759Scope 1 Intensity: 4.39 tCO2e/$MFrontage HoldingsYear: 2023Scope 1: 2,883 tCO2eRevenue: $M 2,027Scope 1 Intensity: 1.42 tCO2e/$MWest Pharmaceutical ServicesYear: 2024Scope 1: 31,327 tCO2eRevenue: $M 2,893Scope 1 Intensity: 10.83 tCO2e/$MRegeneron PharmaceuticalsYear: 2024Scope 1: 80,300 tCO2eRevenue: $M 14,202Scope 1 Intensity: 5.65 tCO2e/$MHalozyme TherapeuticsYear: 2024Scope 1: 1,348 tCO2eRevenue: $M 1,015Scope 1 Intensity: 1.33 tCO2e/$MModernaYear: 2023Scope 1: 11,240 tCO2eRevenue: $M 6,754Scope 1 Intensity: 1.66 tCO2e/$MSarepta TherapeuticsYear: 2023Scope 1: 3,428 tCO2eRevenue: $M 1,243Scope 1 Intensity: 2.76 tCO2e/$MDENTSPLY SIRONAYear: 2024Scope 1: 4,705 tCO2eRevenue: $M 3,793Scope 1 Intensity: 1.24 tCO2e/$MTeleflexYear: 2024Scope 1: 16,256 tCO2eRevenue: $M 3,047Scope 1 Intensity: 5.33 tCO2e/$MMerit Medical SystemsYear: 2023Scope 1: 3,072 tCO2eRevenue: $M 1,257Scope 1 Intensity: 2.44 tCO2e/$MWatersYear: 2023Scope 1: 12,660 tCO2eRevenue: $M 2,956Scope 1 Intensity: 4.28 tCO2e/$MRRRevvityYear: 2023Scope 1: 2,121 tCO2eRevenue: $M 2,751Scope 1 Intensity: 0.77 tCO2e/$MCytokineticsYear: 2024Scope 1: 242 tCO2eRevenue: $M 18Scope 1 Intensity: 13.10 tCO2e/$MAlnylam PharmaceuticalsYear: 2024Scope 1: 3,832 tCO2eRevenue: $M 2,248Scope 1 Intensity: 1.70 tCO2e/$MQuidelOrthoYear: 2023Scope 1: 22,544 tCO2eRevenue: $M 2,998Scope 1 Intensity: 7.52 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MIonis PharmaceuticalsYear: 2024Scope 1: 2,616 tCO2eRevenue: $M 705Scope 1 Intensity: 3.71 tCO2e/$MNateraYear: 2024Scope 1: 5,143 tCO2eRevenue: $M 1,697Scope 1 Intensity: 3.03 tCO2e/$MVertex PharmaceuticalsYear: 2024Scope 1: 8,976 tCO2eRevenue: $M 11,020Scope 1 Intensity: 0.81 tCO2e/$MBio-TechneYear: 2023Scope 1: 3,001 tCO2eRevenue: $M 1,137Scope 1 Intensity: 2.64 tCO2e/$M

How does Bio-Techne's GHG emissions intensity compare to its peers?

In 2023, Bio-Techne reported a Scope 1 emissions intensity of 2.64 tCO₂e per millions USD. Compared to the peer group median of 2.76 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Bio-Techne rank on GHG emissions intensity within its industry?

In 2023, Bio-Techne ranked 12 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Bio-Techne is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to Bio-Techne's GHG Emissions Dataset?
Sign Up